Canada Pension Plan Investment Board’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37,000
| Closed | -$935K | – | 1337 |
|
|
2024
Q4 | $935K | Sell |
37,000
-27,000
| -42% | -$682K | ﹤0.01% | 1030 |
|
|
2024
Q3 | $2.18M | Buy |
+64,000
| New | +$2.18M | ﹤0.01% | 854 |
|
|
2022
Q1 | – | Sell |
-23,600
| Closed | -$912K | – | 1352 |
|
|
2021
Q4 | $912K | Buy |
23,600
+12,600
| +115% | +$487K | ﹤0.01% | 1052 |
|
|
2021
Q3 | $594K | Buy |
+11,000
| New | +$594K | ﹤0.01% | 1117 |
|
|
2017
Q4 | – | Sell |
-5,080
| Closed | -$218K | – | 1178 |
|
|
2017
Q3 | $218K | Sell |
5,080
-9,827
| -66% | -$422K | ﹤0.01% | 1033 |
|
|
2017
Q2 | $552K | Buy |
14,907
+1,320
| +10% | +$48.9K | ﹤0.01% | 977 |
|
|
2017
Q1 | $736K | Buy |
13,587
+7,014
| +107% | +$380K | ﹤0.01% | 942 |
|
|
2016
Q4 | $349K | Buy |
6,573
+413
| +7% | +$21.9K | ﹤0.01% | 895 |
|
|
2016
Q3 | $373K | Buy |
6,160
+1,973
| +47% | +$119K | ﹤0.01% | 907 |
|
|
2016
Q2 | $276K | Buy |
4,187
+1,194
| +40% | +$78.7K | ﹤0.01% | 934 |
|
|
2016
Q1 | $170K | Buy |
2,993
+2,253
| +304% | +$128K | ﹤0.01% | 1015 |
|
|
2015
Q4 | $174K | Sell |
740
-6,712
| -90% | -$1.58M | ﹤0.01% | 1021 |
|
|
2015
Q3 | $1.18M | Buy |
7,452
+7,245
| +3,500% | +$1.15M | ﹤0.01% | 820 |
|
|
2015
Q2 | $78K | Sell |
207
-226
| -52% | -$85.2K | ﹤0.01% | 1147 |
|
|
2015
Q1 | $181K | Buy |
+433
| New | +$181K | ﹤0.01% | 1031 |
|